1
work images in hematology Bone marrow inltration by plasmablastic neoplasm: plasmablastic myeloma or plasmablastic lymphoma? Entsar Eladl and Hong Chang, University of Toronto A B C D E F A 67-year-old HIV-negative man presented with a history of sinus lesions and elevated serum monoclonal immunoglobulin G kappa but no evidence of lytic bone lesions. Serum calcium, creatinine, and complete blood count were normal. Peripheral blood smear was unremarkable. A bone marrow workup showed normocellularity with trilineage hematopoiesis and partial involve- ment by an abnormal population of large cells that exhibited amphophilic cytoplasm, oval nuclei, and variably prominent nucleoli (panel A: Wright-Giemsa stain, original magnication 31000; panel B: hematoxylin and eosin stain, original mag- nication 3400). By immunohistochemistry, these abnormal cells were positive for CD138 (panel C; original magnication 3200), MUM1 (panel D; original magnication 3200), CD56, C-MYC with kappa restriction, negative for PAX5 (panel E; original magnication 3200), CD20, CD45, CD30, CD117, cyclin D1, BCL- 2, BCL-6, HHV8, and ALK1. Epstein-Barr (virus)encoded RNAs (EBERs) were positive by in situ hybridization (panel F; original magnication 3200). The proliferation index by Ki-67 immuno- staining approached 95%. C-MYC translocation was demon- strated by uorescence in situ hybridization (FISH), but no other myeloma-associated chromosomal abnormalities were detected by FISH. A diagnosis of plasmablastic lymphoma (PBL) was rendered. Similar features were seen in his sinus mass. PBL and plasmablastic myeloma are rare yet aggressive he- matologic neoplasms, with identical morphologic features and immunophenotypical proles, which often cause diagnostic challenges. The presence of EBER positivity and absence of myeloma abnormalities detectable by FISH as well as absence of myeloma-dening signs of hypercalcemia, renal failure, anemia, and bone disease (CRAB) in this patient, support the diagnosis of PBL. For additional images, visit the ASH Image Bank, a reference and teaching tool that is continually updated with new atlas and case study images. For more information, visit http://imagebank.hematology.org. DOI 10.1182/blood.2020009735 © 2021 by The American Society of Hematology 1268 blood® 4 MARCH 2021 | VOLUME 137, NUMBER 9 Downloaded from http://ashpublications.org/blood/article-pdf/137/9/1268/1801524/bloodbld2020009735.pdf by guest on 07 March 2021

Bone marrow infiltration by plasmablastic neoplasm

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Bone marrow infiltration by plasmablastic neoplasm

workimages in hematology

Bone marrow infiltration by plasmablastic neoplasm:plasmablastic myeloma or plasmablastic lymphoma?Entsar Eladl and Hong Chang, University of Toronto

A B C

D E F

A 67-year-old HIV-negativeman presented with a history of sinuslesions and elevated serum monoclonal immunoglobulin Gkappa but no evidence of lytic bone lesions. Serum calcium,creatinine, and complete blood count were normal. Peripheralblood smear was unremarkable. A bone marrow workup showednormocellularity with trilineage hematopoiesis and partial involve-ment by an abnormal population of large cells that exhibitedamphophilic cytoplasm, oval nuclei, and variably prominentnucleoli (panel A: Wright-Giemsa stain, original magnification31000; panel B: hematoxylin and eosin stain, original mag-nification 3400). By immunohistochemistry, these abnormalcells were positive for CD138 (panel C; original magnification3200), MUM1 (panel D; original magnification 3200), CD56,C-MYCwith kappa restriction, negative for PAX5 (panel E; originalmagnification3200), CD20, CD45, CD30, CD117, cyclin D1, BCL-2, BCL-6, HHV8, and ALK1. Epstein-Barr (virus)–encoded RNAs

(EBERs) were positive by in situ hybridization (panel F; originalmagnification 3200). The proliferation index by Ki-67 immuno-staining approached 95%. C-MYC translocation was demon-strated by fluorescence in situ hybridization (FISH), but no othermyeloma-associated chromosomal abnormalities were detectedby FISH. A diagnosis of plasmablastic lymphoma (PBL) wasrendered. Similar features were seen in his sinus mass.

PBL and plasmablastic myeloma are rare yet aggressive he-matologic neoplasms, with identical morphologic features andimmunophenotypical profiles, which often cause diagnosticchallenges. The presence of EBER positivity and absence ofmyeloma abnormalities detectable by FISH as well as absence ofmyeloma-defining signs of hypercalcemia, renal failure, anemia,and bone disease (CRAB) in this patient, support the diagnosisof PBL.

For additional images, visit the ASH Image Bank, a reference and teaching tool that is continually updatedwith new atlasand case study images. For more information, visit http://imagebank.hematology.org.

DOI 10.1182/blood.2020009735 © 2021 by The American Society of Hematology

1268 blood® 4 MARCH 2021 | VOLUME 137, NUMBER 9

Dow

nloaded from http://ashpublications.org/blood/article-pdf/137/9/1268/1801524/bloodbld2020009735.pdf by guest on 07 M

arch 2021